The Rabbit Polyclonal anti-ARHGDIB antibody has been validated for WB and IHC (p). It is suitable to detect ARHGDIB in samples from Human. There is 1 publication available.
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This ARHGDIB antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 160-188 amino acids from the C-terminal region of human ARHGDIB.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
ARHGDIB Antibody (C-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.
Expiry Date
6 months
Huang, Zhang, Jiang, Chen, Liu, Ge, Li, Dang, Wen, Liu, Lu, Tang: "RhoGDI? Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation." in: The Journal of biological chemistry, Vol. 290, Issue 17, pp. 11119-29, (2015) (PubMed).
Target
ARHGDIB
(rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
Alternative Name
ARHGDIB
Background
Members of the Rho (or ARH) protein family (see MIM 165390) and other Ras-related small GTP-binding proteins (see MIM 179520) are involved in diverse cellular events, including cell signaling, proliferation, cytoskeletal organization, and secretion. The GTP-binding proteins are active only in the GTP-bound state. At least 3 classes of proteins tightly regulate cycling between the GTP-bound and GDP-bound states: GTPase-activating proteins (GAPs), guanine nucleotide-releasing factors (GRFs), and GDP-dissociation inhibitors (GDIs). The GDIs, including ARHGDIB, decrease the rate of GDP dissociation from Ras-like GTPases (summary by Scherle et al., 1993 [PubMed 8356058]).